Drospirenone-only oral contraceptive: results from a multicenter non-comparative trial of efficacy, safety and tolerability

被引：0
|
作者：
Archer, David [1 ]
Colli, Enrico [2 ]
机构：
[1] Eastern Virginia Med Sch, Dept Obstet & Gynecol, Ghent, Belgium
[2] EXELTIS, Florham Pk, NJ USA
来源：
GYNECOLOGICAL ENDOCRINOLOGY | 2016年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability
    Archer, David F.
    Ahrendt, Hans-Joachim
    Drouin, Dominique
    CONTRACEPTION, 2015, 92 (05) : 439 - 444
  • [2] Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill
    Palacios, Santiago
    Colli, Enrico
    Regidor, Pedro-Antonio
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2019, 98 (12) : 1549 - 1557
  • [3] EFFICACY, SAFETY AND TOLERABILITY OF URAPIDIL - RESULTS OF A MULTICENTER TRIAL
    LIEBAU, H
    HAEHN, KD
    WURST, W
    SOLLEDER, P
    JOURNAL OF HYPERTENSION, 1986, 4 : S141 - S143
  • [4] Tolerability and efficacy of retard form of Indapamide in the treatment of hypertension in elderly patients - (Results of multicenter open non-comparative trial in Russian program ARGUS)
    Kobalava, ZD
    Kotovskaya, YV
    Vereshchagina, GN
    Lukyanchikova, VF
    Nekrutenko, LA
    Nechaeva, GL
    Sklizkova, LA
    Slobodyanyuk, AL
    Filippenko, NG
    Shlyk, SV
    Maximenko, VV
    Moiseev, VS
    KARDIOLOGIYA, 2002, 42 (07) : 25 - 35
  • [5] Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results
    Creinin, Mitchell D.
    Westhoff, Carolyn L.
    Bouchard, Celine
    Chen, Melissa J.
    Jensen, Jeffrey T.
    Kaunitz, Andrew M.
    Achilles, Sharon L.
    Foidart, Jean-Michel
    Archer, David F.
    CONTRACEPTION, 2021, 104 (03) : 222 - 228
  • [6] A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis
    Bunnag, C
    Jareoncharsri, P
    Tunsuriyawong, P
    Pumhirun, P
    Limprasertsiri, S
    Chochaipanichnon, L
    Supiyaphun, P
    Kongpatanakul, S
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2000, 18 (03): : 127 - 133
  • [7] Efficacy and safety of NDC-052 for persistent bronchial asthmatics: Non-comparative, multicenter, phase III trial.
    Park, C.
    Bae, Y.
    Kim, T.
    Cho, Y.
    Moon, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A29 - A30
  • [8] Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
    Chen, Melissa J.
    Jensen, Jeffrey T.
    Kaunitz, Andrew M.
    Achilles, Sharon L.
    Zatik, Janos
    Weyers, Steven
    Piltonen, Terhi
    Suturina, Larisa
    Apolikhina, Inna
    Bouchard, Celine
    Archer, David F.
    Jost, Maud
    Foidart, Jean-Michel
    Creinin, Mitchell
    CONTRACEPTION, 2022, 116 : 44 - 50
  • [9] Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
    Melmed, Shlomo
    Popovic, Vera
    Bidlingmaier, Martin
    Mercado, Moises
    van der Lely, Aart Jan
    Biermasz, Nienke
    Bolanowski, Marek
    Coculescu, Mihail
    Schopohl, Jochen
    Racz, Karoly
    Glaser, Benjamin
    Goth, Miklos
    Greenman, Yona
    Trainer, Peter
    Mezosi, Emese
    Shimon, Ilan
    Giustina, Andrea
    Korbonits, Marta
    Bronstein, Marcello D.
    Kleinberg, David
    Teichman, Sam
    Gliko-Kabir, Irit
    Mamluk, Roni
    Haviv, Asi
    Strasburger, Christian
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04): : 1699 - 1708
  • [10] The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
    Creinin, Mitchell D.
    Angulo, Alicyoy
    Colli, Enrico
    Archer, David F.
    CONTRACEPTION, 2023, 128
12345